These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 31577946)
41. Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes. Sun NY; Chen YL; Lin HW; Chiang YC; Chang CF; Tai YJ; Chen CA; Sun WZ; Chien CL; Cheng WF Cancer Lett; 2019 Mar; 444():20-34. PubMed ID: 30543813 [TBL] [Abstract][Full Text] [Related]
42. Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts. Douagi I; McInerney GM; Hidmark AS; Miriallis V; Johansen K; Svensson L; Karlsson Hedestam GB J Virol; 2007 Mar; 81(6):2758-68. PubMed ID: 17215281 [TBL] [Abstract][Full Text] [Related]
43. SENP3 senses oxidative stress to facilitate STING-dependent dendritic cell antitumor function. Hu Z; Teng XL; Zhang T; Yu X; Ding R; Yi J; Deng L; Wang Z; Zou Q Mol Cell; 2021 Mar; 81(5):940-952.e5. PubMed ID: 33434504 [TBL] [Abstract][Full Text] [Related]
44. Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses. Malli Cetinbas N; Monnell T; Soomer-James J; Shaw P; Lancaster K; Catcott KC; Dolan M; Mosher R; Routhier C; Chin CN; Toader D; Duvall J; Bukhalid R; Lowinger TB; Damelin M Nat Commun; 2024 Jul; 15(1):5842. PubMed ID: 38992037 [TBL] [Abstract][Full Text] [Related]
45. Antitumor activity of type I and type III interferons in BNL hepatoma model. Abushahba W; Balan M; Castaneda I; Yuan Y; Reuhl K; Raveche E; de la Torre A; Lasfar A; Kotenko SV Cancer Immunol Immunother; 2010 Jul; 59(7):1059-71. PubMed ID: 20217081 [TBL] [Abstract][Full Text] [Related]
46. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice. Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550 [TBL] [Abstract][Full Text] [Related]
47. Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod. Wenzel J; Uerlich M; Haller O; Bieber T; Tueting T J Cutan Pathol; 2005 Apr; 32(4):257-62. PubMed ID: 15769273 [TBL] [Abstract][Full Text] [Related]
49. Adjuvant effects of formalin-inactivated HSV through activation of dendritic cells and inactivation of myeloid-derived suppressor cells in cancer immunotherapy. Ohkusu-Tsukada K; Ohta S; Kawakami Y; Toda M Int J Cancer; 2011 Jan; 128(1):119-31. PubMed ID: 20232389 [TBL] [Abstract][Full Text] [Related]
50. Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells. Wang S; Campos J; Gallotta M; Gong M; Crain C; Naik E; Coffman RL; Guiducci C Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7240-E7249. PubMed ID: 27799536 [TBL] [Abstract][Full Text] [Related]
51. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model. Ishii S; Hiroishi K; Eguchi J; Hiraide A; Imawari M Gene Ther; 2006 Jan; 13(1):78-87. PubMed ID: 16107857 [TBL] [Abstract][Full Text] [Related]
52. Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies. Noe P; Wang JH; Chung K; Cheng Z; Field JJ; Shen X; Cortesio CL; Pastuskovas CV; Phee H; Tarbell KV; Egen JG; Casbon AJ Front Immunol; 2023; 14():1272055. PubMed ID: 37942313 [TBL] [Abstract][Full Text] [Related]
53. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses. Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960 [TBL] [Abstract][Full Text] [Related]
54. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Lam KC; Araya RE; Huang A; Chen Q; Di Modica M; Rodrigues RR; Lopès A; Johnson SB; Schwarz B; Bohrnsen E; Cogdill AP; Bosio CM; Wargo JA; Lee MP; Goldszmid RS Cell; 2021 Oct; 184(21):5338-5356.e21. PubMed ID: 34624222 [TBL] [Abstract][Full Text] [Related]
55. Type I IFN-induced, NKT cell-mediated negative control of CD8 T cell priming by dendritic cells. Bochtler P; Kröger A; Schirmbeck R; Reimann J J Immunol; 2008 Aug; 181(3):1633-43. PubMed ID: 18641299 [TBL] [Abstract][Full Text] [Related]
56. XCR1+ dendritic cells promote memory CD8+ T cell recall upon secondary infections with Listeria monocytogenes or certain viruses. Alexandre YO; Ghilas S; Sanchez C; Le Bon A; Crozat K; Dalod M J Exp Med; 2016 Jan; 213(1):75-92. PubMed ID: 26694969 [TBL] [Abstract][Full Text] [Related]
57. Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity. Rizza P; Moretti F; Belardelli F Autoimmunity; 2010 Apr; 43(3):204-9. PubMed ID: 20187707 [TBL] [Abstract][Full Text] [Related]
58. Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb. Uehara J; Ohkuri T; Kosaka A; Ishibashi K; Hirata Y; Ohara K; Nagato T; Oikawa K; Aoki N; Harabuchi Y; Ishida-Yamamoto A; Kobayashi H Biochem Biophys Res Commun; 2017 Aug; 490(2):521-527. PubMed ID: 28624449 [TBL] [Abstract][Full Text] [Related]
59. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts. Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665 [TBL] [Abstract][Full Text] [Related]
60. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity. Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]